Adolescents who use cannabis face a dramatically increased risk of developing severe psychiatric conditions, according to a comprehensive new study published in the prestigious JAMA Health Forum. The research, which tracked hundreds of thousands of teenagers, reveals that cannabis use during the teenage years doubles the likelihood of being diagnosed with psychotic and bipolar disorders by young adulthood.
Study Details and Key Findings
The American research team followed an extensive cohort of 463,396 adolescents, aged between 13 and 17 years, through to the age of 26. By analysing electronic health record data from routine paediatric visits conducted between 2016 and 2023, the scientists established a clear and concerning link. The findings demonstrated that any cannabis use reported within the previous 12 months during adolescence was associated with a twofold increase in the risk for both psychotic and bipolar disorders.
Furthermore, the study identified a significantly higher risk of developing depressive and anxiety issues among these young cannabis users. Crucially, the research design showed that cannabis use typically preceded the psychiatric diagnoses by an average of 1.7 to 2.3 years, strengthening the evidence that adolescent cannabis exposure acts as a potential risk factor for subsequent mental illness.
Social Disparities and Potency Concerns
The investigation also uncovered a troubling social disparity. Cannabis use was found to be more common among teenagers residing in poorer socioeconomic areas. This highlights a potential public health inequity that requires targeted intervention strategies.
Study co-author Dr. Lynn Silver of the Public Health Institute in Oakland, California, emphasised the urgency of the situation. "As cannabis becomes more potent and aggressively marketed, this study indicates that adolescent cannabis use is associated with double the risk of incident psychotic and bipolar disorders, two of the most serious mental health conditions," she stated.
Dr. Silver added a powerful call to action: "The evidence increasingly points to the need for an urgent public health response - one that reduces product potency, prioritises prevention, limits youth exposure and marketing and treats adolescent cannabis use as a serious health issue, not a benign behaviour."
Broader Context and Research Significance
Cannabis remains the most widely used illicit substance among American youth. According to the 2024 National Survey on Drug Use and Health, over 10 percent of all Americans aged 12 to 17 reported using cannabis within the last year. Compounding the risk is the fact that modern cannabis products are becoming increasingly potent, a trend documented by separate research.
This study's methodology sets it apart from many previous investigations. Rather than focusing solely on heavy or dependent users, it examined any self-reported cannabis use, gathered through universal screening of teens during standard paediatric care. This approach provides a more comprehensive picture of the population-level risk.
Lead author Dr. Kelly Young-Wolff of the Kaiser Permanente Division of Research explained the robustness of the findings. "Even after accounting for prior mental health conditions and other substance use, adolescents who reported cannabis use had a substantially higher risk of developing psychiatric disorders — particularly psychotic and bipolar disorders," she said.
"This study adds to the growing body of evidence that cannabis use during adolescence could have potentially detrimental, long-term health effects," Dr. Young-Wolff concluded. "It’s imperative that parents and their children have accurate, trusted, and evidence-based information about the risks of adolescent cannabis use."
